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Abstract
Background: We investigated the effect of Retinoic acid in the growth of contralateral lung after
pneumonectomy.
Methods: Twentyone adult male Wistar albino rats from the same colony were used. They were
divided into three groups (Group A, B and C). Group A undergone only left posterolateral
thoracotomy. In Group B and C, the rats were subjected to left posterolateral thoracotomy and
left pneumonectomy. In Group C, rats were given intraperitoneal Retinoic acid during the
operation and continued to be given everyday postoperatively. Rats were sacrificed on the 10th day
and their total body, right lung weights and right lung volumes were measured.
Results: The volume and weight indices of the lung were found to be higher in Group C. In
histopathological examination, there was a reduction in the mean number of alveoli in Group B and
C. A significant rise in the mean dimension and average wall thickness of the alveolar structure were
determined in Group C.
Conclusion: Retinoic acid contributes to the compensatory growth of the residual lung tissue.
Introduction
One of the most serious problems that may develop after
lung resection is the situation that the existent remaining
lung tissue becomes insufficient and can not provide
enough oxygenization for the body. In most of these
cases, no symptom is seen during rest, but with efforts,
complaints like shortness of breath, palpitation and quick
tiring due to insufficient oxygenization occur. This situa-
tion restricts the functional capacity, lengthens the time to
return to daily activities and worsens the postoperative
quality of life [1,2]. The hospitalization and loss of labour
also increase.
There occurs some growth in the residual lung tissue phys-
iologically postoperatively. The volume, weight, collagen
content, protein and cell size increase in the residual lung
[3]. However, its not being in desirable degrees creates
problems. This is especially important for the patients
having limited respiratory reserve in the respiratory func-
tion tests performed preoperatively. Thus, providing a
dimensional increase in the residual lung tissue contrib-
utes to the improvement of respiratory functions. For this
purpose, lots of pharmacologic agents have been used
but, a few of them have given positive results. Retinoic
acid (RA) is a product of Vitamin A metabolism and pro-
motes cell growth. It is a powerful signaling molecule con-
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factors, the nuclear RA receptors. It is one of the important
factors controlling the growth of foetal lung and is neces-
sary for the development of the lung. RA also affects the
development of trachea and bronchopulmonary struc-
tures besides lung tissue [4,5]. The use of RA in lobectomy
or pneumonectomy cases postoperatively increases the
lung growth and may create a positive effect on its func-
tions. If RA might be effective, the growth in the residual
lung tissue would rise the quality of life in the applied
lung resection cases and would shorten the period to
return back to normal life.
The purpose of this experimental study is to investigate
whether there will be a growth in the volume and weight
of the residual lung and an increase in the functional
capacity in rats that undergone pneumonectomy, with RA
treatment administered exogenously. If this becomes true,
an important additional respiratory reserve contribution
can be achieved in cases that undergone lobectomy and
pneumonectomy, especially in those with limited respira-
tory reserve with the improvement of new treatment strat-
egies. It may be possible to perform lung resection such as
pneumonectomy easily in patients accepted as to be inop-
erable due to limited respiratory capacity as well.
Materials and methods
Twentyone adult male Wistar albino rats with an average
of 220–260 g body weight from the same colony were
used. The purposes of using rats are their easy availability,
safety and the high ratio of repeating the experiment [6].
The rats were cared for in accordance with the Guide for
the Care and Use of Laboratory Animals. They were kept
at 21° to 23°C, with controlled humidity, and a dark-light
cycle of 12 to 12 h. Food and water were available ad libi-
tum. The experimental protocol was approved by Dokuz
Eylul University, School of Medicine, Animal Care and
Use Committee.
Rats were divided into three groups randomly (Group A,
B, and C). 1- Group A: Sham (n = 7), 2- Group B: Control
(n = 7), 3- Group C: RA (n = 7). All rats were anesthetized
by administering Ketamine (100 mg/kg/intraperitoneal)
and Xylazine (5 mg/kg/intraperitoneal), their body
weights were measured, and after tracheostomy, they were
intubated with 16G catheter. Rats were given ventilator
support using room atmosphere in volume control mode
throughout operation. Ninety per minute respiration
count and 15–20 ml/kg minute volume were provided
during ventilation (Hugo sacs, rodent ventilator, Ger-
many). Because mediastinal pleura is not complete, and is
quite weak in rats. Unless a positive pressure ventilation is
achieved, pleura is sutured and both lungs collapse even
when only one pleura is opened [7].
In operation, rats were put into right posterolateral posi-
tion; the site was shaved and disinfected by using povi-
done iodine. Group A has undergone only left
posterolateral thoracotomy and the layers were closed
properly after bleeding control.
Left posterolateral thoracotomy was applied to the rats in
Group B and C, and left pneumonectomy was performed
after ligation of hilus done with 4-0 silk suture. Then,
bleeding and air leakage controls were done and the tho-
racotomy was closed properly.
When the spontaneous respiration was achieved, rats were
extubated, tracheostomy was closed and they were kept in
different cages. No drug treatment was applied to Group
A and B. In Group C, rats were given intraperitoneal RA
(0.5 microgram/g) during operation and the same dosage
was continued to be given everyday postoperatively
(Retinoic Acid Empirical Formula (Hill Notation) C20
H28 02, Formula weight: 300.44 Cas Number: 302-79-4,
R-2625-100 mg, 98% (HPLC), powder, Sigma, USA). In
the first 24 hours rats were given Buprenorphine 0.03 mg/
kg every 8 hours subcutaneously. They were given food
and water as much as they wanted. Wound infection has
occurred in one rat (in Group B) and this rat was excluded
from the experiment protocol. Rats were sacrificed at the
end of 10th day by administering lethal dose of Ketamine
intraperitoneally. Then, their total body weight and right
lung weight were measured. In order not to be affected by
the tissue water, right lung weight was taken after lung tis-
sue was removed and dried at room temperature over 3
hours.
Right lung volume was calculated according to the
method defined by Scherle [8]. At this point, after placing
and fixing a catheter to the right lung bronchi related with
trachea, lung was inflated until it became well expanded
and the volume was calculated. In order to prevent vol-
ume faults that can occur, right lung volume measure-
ment was taken after each lung tissue had been expanded
at maximum. The volume (ml) and weight (g) of the lung
was compared with the body weight prior to sacrifice and
the indices of lung weight and volume were found.
Lung Volume Index (LVI) = Lung volume/Total body
weight (ml/kg)
Lung Weight Index (LWI) = Lung weight/Total body
weight (g/kg)
The results were evaluated statistically. In order to evalu-
ate the difference among experiment groups, Wilcoxon
Signed Ranks Test and Kruskal Wallis Test were used. Sta-
tistically p > 0.05 was accepted as insignificant, and p <
0.05 as significant in these tests.Page 2 of 9
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essed for paraffin embedding and then sectioned at 5 μm.
Hematoxylin-Eosin stained sections were used to evaluate
histopathological findings by light microscopy.
Results
The weights of the rats were measured in grams at the ini-
tial stage of the experiment. When the experiment was fin-
ished, the rats were weighed once more. The body weight
differences for each subject were calculated and their val-
ues were found as percentage. In Group A, B, and C; there
are weight increases of 1.9%, 2.0% and 3.4% as the mean
values, respectively. As it is seen, there is some weight
increase in all groups at the end of the experiment. The
most increase is observed in RA group.
At the end of the experiment, the right lungs of rats were
removed (Fig 1). The right lung volumes of the rats were
measured in millilitre. Right lung volumes were between
2.8–3.4 ml (mean 3 ml) in Group A, 3.3–4.2 ml (mean
3.7 ml) in Group B, and 3.9–4.8 (mean 4.3 ml) in Group
C.
Right lung volumes of Group B compared to Group A, and
Group C to group A and B were found to be more.
Lung volume indices were determined for each group.
Lung volume indices were between 10.8–13.4 ml/kg in
Group A (mean 12.1), 13.3–17.5 ml/kg in Group B (mean
15.0), and 15.2–19.6 ml/kg in Group C (mean 17.6).
Lung volume indices were found higher in Group B com-
pared to Group A, and in Group C compared to Group A
and B (Fig 2).
At the final stage of the experiment, right lung weights of
the rats were measured in grams. They were between
2.40–2.94 g in Group A (mean 2.68 g), 2.70–3.31 g in
Group B (mean 2.99), and 3.44–3.78 g in Group C (mean
3.59).
Right lung weight was found to be more in Group B com-
pared to Group A, and in Group C compared to Groups A
and B.
Lung weight indices were determined for each group.
Lung weight indices in Group A were between 9.2–12.0 g/
kg (mean 10.8), 11.0–13.5 g/kg in Group B (mean 12.1),
and 13.8–15.8 g/kg in Group C (mean 14.6). As it is seen,
lung weight indices increased in Group B compared to
Group A, and in Group C compared to Groups A and B
(Fig 3).
There was no statistically significant difference between
the body weights of Groups when the initial and final
days of the experiment were compared (p > 0.05).
When the right lung volumes among the groups were
compared at the end of the experiment, there was statisti-
cally significant difference between Group A-B (z = -2.4, p
< 0.05), and Group A-C (z = -2.4, p < 0.05) and a statisti-
cally significant difference between Group B-C (z = -2.2, p
< 0.05).
At the end of the experiment, lung volume indices of all groups were comparedFig re 2
At the end of the experiment, lung volume indices of all 
groups were compared. It was found higher in Group C. 
There was statistically significant difference in Group B and C 
compared to Group A (p < 0.05). Also, a statistically signifi-
cant difference was found between Group B and C (p < 
0.05).
At the end of the experiment, right lung tissue of rats was removedFigure 1
At the end of the experiment, right lung tissue of rats was 
removed. It was seen extend and lobulate position.Page 3 of 9
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statistically significant difference in Group B and C com-
pared to Group A (z = -2.4, p < 0.05). A statistically signif-
icant difference was found between Group B and C (z = -
2.2, p < 0.05).
The right lung weights were compared and there found to
be a statistically significant difference between Group A
and B (z = -2.2, p < 0.05), and statistically significant dif-
ferences between Group A-C and Group B-C (z = -2.4, p <
0.05).
When the lung weight indices were compared, a statisti-
cally significant difference was found between Group A
and Group B (z = -2.4, p < 0.05), and significant difference
between Group A and Group C (z = -2.6, p < 0.05). There
was a statistically significant difference between Group B
and Group C (z = -2.4, p < 0.05).
In all these statistical evaluations, Wilcoxon Signed Ranks
Test, one of nonparametrical tests, was used.
The values of body weight on the 1st and 10th days and the
body weight increase and total body weight percentage
values at the end of the experiment were subjected to
mutual statistical evaluation and no significant difference
was found.
Right lung volume measurements were found to be statis-
tically very significant in respect to volume among Groups
A, B and C (x2 = 15.67, sv = 2, p < 0.001). Lung volume
indices were found to be statistically very significant
among Groups A, B and C (x2 = 15.96, sv = 2, p < 0.001).
Right lung weight measurements were found to be statis-
tically very significant from the point of weight among
Groups A, B and C (x2 = 15.39, sv = 2, p < 0.001). Also,
lung weight indices were statistically very significant
among Groups A, B and C (x2 = 14.64, sv = 2, p < 0.05)
(Table 1).
These evaluations were made by means of a nonparamet-
ric test, Kruskal Wallis Test.
In the histopathological examination, the alveoli num-
bers in per 5 high-power fields of each histopathological
preparation prepared separately for each subject were cal-
culated and in the end, individual means of these values
were found for each group. As a result, the mean number
of alveoli in per 5 high-power fields was found to be 24.0
± 1.3 in Group A, 20.6 ± 1.1 in Group B, and 16.8 ± 1.1 in
Group C. A statistically significant difference was found
between Group A and Group B (p < 0.05), and significant
difference between Group A and Group C (p < 0.05). Also,
there was a statistically significant difference between
Group B and Group C (p < 0.05).
The mean alveolus dimension was found by measuring 5
different alveoli dimension in each histopathological
preparation prepared separately for each subject and then
by calculating the mean of these values for each group.
The mean alveolus dimension was found as 1.76 ± 0.04 μ
in Group A, 2.92 ± 0.02 μ in Group B, and 4.06 ± 0.03 μ
in Group C. A statistically significant difference was found
between Group A and Group B (p < 0.05), and significant
difference between Group A and Group C (p < 0.05). Also,
there was a statistically significant difference between
Group B and Group C (p < 0.05).































p 0.313 0.509 0.713 0.485 0.000 0.000 0.000 0.001
p: p value (Significance was accepted as p < 0.05.)
At the end of the experiment, lung weight indices of all groups were comparedFig re 3
At the end of the experiment, lung weight indices of all 
groups were compared. It was found higher in Group C. 
There was statistically significant difference was found 
between Group A and Group B (p < 0.05), and significant dif-
ference between Group A and Group C (p < 0.05). Also, 
there was a statistically significant difference between Group 
B and Group C (p < 0.05).Page 4 of 9
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the wall thickness of 5 different alveoli in each his-
topathological preparation prepared separately for each
subject, and then by calculating the means of these values
for each group. The mean alveolar wall thickness was 0.68
± 0.02 μ in Group A, 1.0 ± 0.04 μ in Group B, and 1.2 ±
0.04 μ in Group C (Fig 4, 5, 6). A statistically significant
difference was found between Group A and Group B (p <
0.05), and significant difference between Group A and
Group C (p < 0.05). However, there was not a statistically
significant difference between Group B and Group C (p >
0.05).
Discussion
The main problem in applied lung resection patients, who
indeed have a limited capacity of respiration, is the respi-
ration functioning efficiency problems that can be
encountered after the operation. This situation is not so
common because preoperatively the patients are sub-
jected to respiratory function tests by spirometry, their
arterial blood gas is examined and if needed, their quanti-
tative ventilation-perfusion scintigraphies are taken. Sur-
gical process is performed according to these results if
patients are suitable. In addition, the remaining lung tis-
sue is also not healthy in these patients and most of which
cilliary functions are out of order, compliance is
decreased, and have damage due to chronic infection [9].
In conclusion, residual lung may be in difficulty in meet-
ing the sufficient respiration during an effort postopera-
tively. Such situation decreases the functional capacity
and lengthens the time to return to daily activities [10].
Such problems developing postoperatively are usually
seen in pneumonectomy patients. But, also lobectomy
sometimes leads to reduction of lung function whether
patients complain of dyspnea on effort or not. In addi-
tion, compensatory lung growth is not a response only
peculiar to pneumonectomy patients. Regenaration of the
lungs also occur in patients who had undergone whether
anatomical surgical procedure such as lobectomy and seg-
mentectomy or nonanatomical surgical procedure like
wedge resection. Rannels et al. reported that this regener-
ation response occurs via adrenal steroids and growth hor-
In Group C, a significant increase in the dimensions and thickening in the walls of alveoli was observ d (Hematoxylin-Eosin, origi al magnifica ion ×200)Figure 6
In Group C, a significant increase in the dimensions and 
thickening in the walls of alveoli was observed (Hematoxylin-
Eosin, original magnification ×200).
In Group A, normally lung tissue was observed on his-topathological examination (Hematoxylin-Eosin, orig nal mag-nificati n ×200)Figure 4
In Group A, normally lung tissue was observed on his-
topathological examination (Hematoxylin-Eosin, original mag-
nification ×200).
In Group B, an increase in the dimensions of alveoli on lung tissue was observed (Hematoxylin-Eosin, original mag ifica-on ×200)Fig re 5
In Group B, an increase in the dimensions of alveoli on lung 
tissue was observed (Hematoxylin-Eosin, original magnifica-
tion ×200).Page 5 of 9
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restorative process. On the contrary, the space occurring in
hemithorax due to compensatory lung growth fills in time
and no air space remains in most of the patients [11]. In
addition, Kaza et al. have reported that, compensatory
lung growth after lobectomy occurs with cellular hyper-
plasia in early period and with cellular hypertrophy in late
period [12,13]. In this study, compensatory lung growth
after pneumonectomy is just a model to evaluate the pos-
sible role of retinoic acid in regeneration of the lung.
Postpneumonectomic compensation develops in two
phases. In the initial phase of active cellular growth, septal
thickening, lengthening in bronchioalveolar tract and
limited functional adaptation occur together. In the late
phase, septal remodeling restores the normal alveolar
structure, and this phase occurs together with great func-
tional increase. When the compensatory lung growth is
complete; alveolar and capillary cells and the surface area
of blood gas barrier protect their position mostly [14,15].
Gaining a dimensional increase in residual lung tissue
contributes to the improvement of respiratory functions.
A number of pharmacologic agents have been used for
this purpose. One of these is RA [16,17]. Cell culture pro-
liferation of Type 2 pneumonocytes can be induced by
means of RA treatment. Besides, RA increases the produc-
tion of surfactant and alveolization. It also increases the
collagen on the walls of respiratory tract. In addition, it
plays an important role in the alveolar epithelial cell pro-
liferation. It increases the mechanical tightness in lung tis-
sue and induces the progressive compensatory growth of
new alveolar tissue. RA increases the endothelial cells and
capillary growth selectively. Yet, it does not affect the
growth of the other alveolar cell types [16].
RA has been used in lots of studies because of these
known effects. One of these studies is randomized, dou-
ble-blind, feasibility study carried out by Roth et al. In this
study, 148 subjects with chronic obstructive pulmonary
disease and whose primary component was emphysema
were divided into three groups and received low, high
doses of RA and placebo, respectively. This treatment
lasted for six months. In this study, retinoid-related side
effects were found to be common but mild. In conclusion,
with the administration of RA, there were no definitive
clinical benefits in the patients. However, time and dose-
dependent changes in diffusing capacity of the lung for
carbon monoxide and health related quality of life were
observed in RA group. The authors stated that, these
results supported the possibility of biological activity by
means of the administration of RA and for this reason
there is a need for more investigation [18].
In this study, the compensatory growth occurring in the
contralateral lung by administering RA to the rats after left
pneumonectomy was controlled. It was administered to
the Group C as 0.5 microgram/g for 10 days. Lung volume
indices and lung weight indices were used for the evalua-
tion of the results. These are the values that can be calcu-
lated quantitatively and that can give information about
lung growth.
There was some weight increase in the group to which RA
was administered. This may be explained by the knowl-
edge that, Vitamin A generally plays a part in the cellular
growth of all tissues. However, when the weight gain is
compared with the other groups, it is seen that it is not sig-
nificant statistically (p > 0.05).
When the rats were sacrificed, right lung tissues were
examined macroscopically both when those were in tho-
rax and those were removed. It was observed that right
lung tissue showed herniation to the left hemithorax
much more in Group C, and partially in Group B and C
anteriolaterally, and more from posterior prevertebral
space. Those posterior herniations seen more commonly
after left pneumonectomy are more in Group C shows a
proportionally increased herniation with right lung
growth.
Right lung tissues in each of the three groups were
removed by turning from the right main bronchus and
separating the surrounding fibrotic adhesions. A very care-
ful dissection should be performed in all these steps as
paranchyme destruction may affect the lung weight, cause
air leakage and thus lead to wrong volume measurements.
Total volume of the lungs of rats is generally between
5.0–5.5 ml although it shows changes from the point of
age and sex. Right lung volumes in Group B showed
increase compared to Group A, and in Group C when
compared to Groups A and B. Average right lung volume
to which RA administered reached above 4 ml. This situa-
tion verifies the alveolar expansion and the size increase
due to this. The reason for choosing the 10th day as the
measurement time is that the upregulation of molecular
mediators in growth period occurs in this duration. It was
reported previously that the right lung growth reached
plateau between 10th and 21th days [19]. Therefore, a 50%
or more volume increase was determined with a ten-day-
treatment protocol. This is a little more above than
expected. However, how long the RA treatment would
continue and when the maximum response would be
were not known thoroughly, a ten-day-treatment program
was applied. Some more studies should be carried out on
RA in respect to duration and response axis depending on
this time.Page 6 of 9
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culated quantitatively. Since there is the body weight in
denominator part, it is affected negatively by the weight
increase occurred in rats. Yet, the weight increase and the
volume growth will lead to some increase in lung tissue of
the rats. Thus, the changes in these two ratios will balance
each other, and a reliable value will be obtained as a
result. In our study, the lung volume indices in Group B
increased compared to Group A, and in Group C when
compared to Groups A and B. The mean increase in index
of Group C is about 45–50%. This shows that, when the
most weight increase in Group C is taken into account, the
lung volume increase in the group administered RA is
much more than the others. The amount in the volume
increase also affects the index. As the lung volume index
determines the volume amount of lungs according to the
body weight, it can give information only about the lung
volume amount, and it is not a functional indicator.
Mean rat dry lung weight is between 5–9 g though it
shows differences from the point of weight, age and sex.
When the right lung weights are evaluated, an increase
about 20% in Group B, and about 40% in Group C were
observed. From this point of view it is understood that the
compensatory lung growth caused some increase in the
lung weight. The administration of RA doubled this
increase. Of course, as the weight increase in Group C is
more than the other groups, the lung weight to occur
would be affected from this situation. In other words, the
final lung weight increase should be accepted a little lower
than the value for Group C. However, this situation
should not overshadow the existing significant difference.
In the evaluation of the lung tissue growth, the lung
weight index value can be calculated quantitatively and
similarly to the volume index. It can be obtained dividing
the provided lung weight by total body weight. As in the
volume index, since the body weight is in the denomina-
tor, it is negatively affected by the weight increase
occurred in rats. However, since the increase occurred in
lung weight shows a parallelism to total weight gain, lung
weight index may remain fixed without being affected
from these. The lung weight indices calculated at the end
of the experiment increased in Group B compared to
Group A, and in Group C compared to other groups. The
increase in this index in Group C is about 40–45% as an
average. That is, lung weight increase is more in the rats of
administered RA. Since the lung weight index determines
the weight amount of lungs according to the body weight,
it can give information only about lung size, and it is not
a functional indicator. On the other hand, the informa-
tion reached shows that RA leads to a real growth in the
lung tissue, and that the alveolar surface on the expands as
its tissue weight has increased, and thus these result in an
increase in the total effective lung volume. This shows that
the lung growth by administration of RA after pneumon-
ectomy is increased significantly as a result of the evi-
dences of the increase in these two indices.
In the investigation of the experiments carried out on the
postpneumonectomic lung growth, the studies of Kaza et
al. attract attention [19]. Kaza et al. indicated the positive
effects of RA and claimed that it provides a significant
functional contribution. The same authors used epider-
mal growth factor and keratinocyte growth factor for this
purpose, and again reached successful results [12,20].
Epidermal growth factor normally plays an important role
in prenatal and postnatal lung development. In postresec-
tional lung growth, on the other hand, this can be
explained by the increase in the amount of growth factor
receptors of residual lung tissue. On the other side, kerat-
inocyte growth factor plays a role in pneumocyte prolifer-
ation and lung development. Postresectional lung tissue
also induces new alveolar formation.
Sakamaki et al. used hepatocyte growth factor for the
same purpose [21]. Hepatocyte growth factor has
mitogenic and morphogenic actions on lung epithelial
cells. As a result of the study, it was found that hepatocyte
growth factor increased the deoxyribonucleic acid synthe-
sis in lung epithelial cells in rats undergone pneumonec-
tomy and that it was a pulmotrophic factor.
Desai et al. investigated RA from the point of its effect on
lung morphogenesis in mouse foregut cultures and
reported that RA affected the mesodermal proliferation
and induced fibroblast growth factor expression [22].
Nevertheless, Sakurai et al. observed in their experimental
study that compensatory lung growth was angiogenesis-
dependent and was accelerated by vascular endothelial
growth factor but not affected by fibroblast growth factor
[23].
Finally, all these growth factors can be effective on com-
pensatory lung growth. They achieve these effects usually
by providing the upregulation of their own receptors in
lung tissue. Among these, the lung growth most resem-
bling to the result obtained by RA was achieved by using
keratinocyte growth factor and epidermal growth factor.
RA was preferred in this study due to its easy availability,
cheapness, easy usage and low side effect incidence.
In our study, histopathological results were evaluated in
addition to lung weight index and lung volume index.
There was no pathological finding in Group A (Fig 4). An
increase in the dimensions of alveoli in the right lung tis-
sue of Group B was observed (Fig 5). We also observed a
significant increase in the dimension of the alveoli inPage 7 of 9
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determined (Fig 6).
In the histopathological examination, the mean alveoli
number in per 5 high-power fields was found to be the
most in Group A, and this value got less in Group B and
Group C. If the mean alveolar dimension values are to be
compared among groups, there was nearly a 50% increase
in Group B compared with Group A, and this increase out-
ran the value of Group A twice as much as Group C.
When the mean alveoli thickening values were compared
among groups, there was a 30% increase in Group B com-
pared with Group A, and a 70% increase in Group C com-
pared with Group A.
In conclusion, we think that the fall in the mean alveoli
number in Group B and C results from the alveolar hyper-
trophy developing in these groups. The increases in the
dimension and wall thickness of the alveoli in Group B
and C lead to decrease in the number of alveoli for per
unit field.
The mean alveolus dimension and the mean alveolar wall
thickness were found increased in Group B compared
with sham group and this supports the postpneumonec-
tomic compensatory lung growth expected to occur to
some degree normally. These increases were observed to
be more in Group C. This aspect partially supports the
positive effects of RA on compensatory lung growth. How-
ever, the mean alveolar wall thickness of Group B and C
was compared statistically, and there was not a statistically
significant difference between Group B and Group C (p >
0.05). This situation may support that, the increase of the
mean alveolar wall thickness on pneumonectomy nor-
mally occurs, and RA has not much affected this value.
The initial stimulus of the compensatory lung growth to
occur during postpneumonectomic period is the mechan-
ical tightening in the residual lung tissue. This tightening
will increase the wall tightening of the cells in the existing
tissue and this will possibly lead to expansion in volume.
The compliance in the expanded lung tissues will increase
and try to fill the area by moving towards the pneumon-
ectomic space. These areas physiological changes are
observed as routine. Yet, the compensation occurred dif-
fers from an individual to another, and its amount and
effectiveness are different. In order to solve this problem,
RA can be used in the light of the information we
obtained. RA administration in the early postoperative
period increases the alveolar capillary amount and the
size of endothelial cells and causes the formation of new
capillaries. As a result, the celluler growth increases and
lung functions improve [24]. Septum thickens is an
important ratio. The increase occurred in the amount of
capillaries can be explained by the increase in the vascular
endothelial growth factor. Administration of RA increases
both the upregulation of its own receptors and the
amount of growth receptors in the residual lung tissue.
Epidermal growth factor may play a role in this process. In
this way, there occurs a restoration in the levels of all pro-
tein, Deoxyribonucleic acid, collagen and elastin in the
residual lung due to this complex receptor-mediator rela-
tion that took place [15,25].
It is controversial how long the RA treatment will last. In
some studies, it is indicated that there is a ten-day-treat-
ment period, and if more, that there occurs a stagnation
period in lung growth [19]. An evident growth takes place
at the end of the first week. The remodeling of the lung
takes place in 21 days in normal people. As a result, it is
thought that during postpneumonectomic early period, a
few weeks treatment is enough. The usage of RA for more
than one month is controversial. The dosage to be used is
also an important subject. A suitable dosage not having
side effects and showing physiological effects should be
determined. Finally, RA is deposited in fat, and high dos-
age for a long time may lead to toxicity.
Conclusion
Protecting the body and survival, and securing a postresec-
tional compensatory lung growth, can be accelerated by
administering RA exogenously. Starting the treatment in
the early period will secure to obtain satisfactory results.
Lung growth due to RA administration should be carried
out to increase the comfort and quality of life of these
patients. Thus, the hospitalization period and drug usage
may decrease, the resistance of the patient to environmen-
tal factors and microorganisms will increase, annual doc-
tor visit number may lessen, and the necessary additional
strength to continue daily activities of the patients having
limited lung function capacities can be provided. It may
not be possible to compensate completely the function of
lung tissue by this treatment. However, due to the positive
effects of RA mentioned earlier, growing the residual lung
tissue may cause not to feel the functional loss or to feel it
much less. When the improvement in living comfort of
the patients is taken into account, this treatment protocol
can be a choice to be tried in necessary situations. Never-
theless, all these views should be arranged in terms of the
results to be obtained from clinical Phase 1 and Phase 2
studies that RA is administered on human.
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